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Interdisciplinary Case Conference  
HIV: Still Deadly After All These Years  










“It's not going to happen to me.  And I'm here saying that it can happen to anybody, even 
me, Magic Johnson."  These words were spoken by basketball hall-of-famer Earvin 
"Magic" Johnson at a press conference on November 7, 1991, to the shock of an entire 
nation.  Johnson represents one of the first sports celebrities to publicly announce his 
HIV-seropositive status.  A star basketball player who is HIV positive?  How could this 
have happened? 
In 1992, Magic played in the NBA All-Star Game and on the gold-medal-winning U.S. 
Olympic basketball team.  He served as head coach of the Lakers in 1994 and returned as 
a player on the team in 1996, but decided it was time to retire and channel his energies 
into other arenas outside of basketball.  Currently, Johnson is CEO of his own business, 
Magic Johnson Enterprises (MJE).  He also has established the Magic Johnson 
Foundation, which helps inner-city communities deal with issues surrounding HIV/AIDS 
and raises funds for research and prevention efforts.  His time is also spent with his wife 
and three children. 
Johnson exercises regularly and eats a healthy diet.  He currently does not experience any 
of the symptoms associated with HIV infection or AIDS. 
Although Magic Johnson tested positive for HIV in 1991, his routine HIV tests show that 
his virus load is currently at undetectable levels and does not show AIDS-related 
symptoms.  Thus, Johnson is considered a non-progressor.  Many patients who are non-
progressors live with HIV without major health complications and their immune system 
seems to keep the virus under control.  Progressors are patients who have uncontrollably 
high virus load levels and advance to AIDS quickly, usually within five years after 
infection. 
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What keeps Magic Johnson alive and symptom free?   
Magic Johnson has worked with Dr. Michael Mellman, his personal physician for the 
past 20 years, to try to keep the virus under control using a combination of antiretroviral 
drugs.  This combination therapy is termed HAART or Highly Active Anti-Retroviral 
Therapy.  The "drug cocktails" that make up a HAART regimen combine the power of 
multiple drugs to block multiple targets in the HIV life cycle.  Central to Magic's therapy 
regimen is a drug called Combivir®, a combination of two drugs:  lamivudine and 
zidovudine, which are nucleoside reverse transcriptase inhibitors.  You may be familiar 
with zidovudine by another name, AZT.  HAART regimens can cost an average of 
$1,000 per month or more depending on the source and type of drugs administered. 
Johnson has been working as a spokesperson for GlaxoSmithKline, the company that 
produces Combivir®. Most recently he has entered into a partnership with Abbott 
Laboratories Inc. to address health disparities among minorities, particularly on HIV 
prevention and testing. In 1985, Abbott Laboratories Inc developed the first licensed test 
to detect HIV antibodies. The medication Magic Johnson takes is not a top secret magic 
bullet but rather a commercially available antiretroviral treatment.  Thus, the same 
medication that Magic Johnson takes to control his HIV infection is available to everyone 
who is HIV-positive. 
Questions 
1. What is the difference between HIV and AIDS; what are some symptoms 
associated with acute phase HIV infection; what are the symptoms of AIDS?  
 
2. List and explain:  
a. the major routes of HIV transmission. 
 
b. positive prevention.  
 
3. Based on the HIV life cycle, propose potential anti-HIV treatment targets.  Which 
targets would be most effective in blocking HIV infection?  Which targets would 
be least effective?  
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4. What type of unique therapeutic challenges does a patient with AIDS face 
compared to patients who are living with other types of chronic diseases (e.g., 
diabetes, cardiovascular diseases, or osteoarthritis)?  
 
 
5. What is the advantage of using multiple targets during HAART (Highly Active 
Anti-Retroviral Therapy)? Do you agree with the statement "The drugs he takes 




6. HIV attacks the immune system.  How does this affect the type and number of 
drugs that are prescribed to patients with AIDS?  What are some additional 
considerations that health care providers should have when treating patients on 
HAART?  
 
7. As a spokesperson for GlaxoSmithKline and now for Abbott Laboratories Inc.,  
a) What impact will Magic Johnson have on how HIV-positive patients are 
viewed?   
 
b) What influence will he have on the future of Abbott Laboratories Inc?  On 
other HIV-positive African-Americans?  
 
c) What ethical aspects can you think of associated with using Johnson as a 
spokesperson by GlaxoSmithKline or Abbott Laboratories Inc.? 
 
d) What benefits are associated with Magic Johnson's announcement 
concerning his HIV-positive status?  What risks or drawbacks can you 
think of associated with his announcement?  
 
